RPTX240517C2500
- 1.05
- 0.000.00%
Repare Therapeutics Newsroom
Repare Therapeutics: A Strong Buy on Robust Financials and Promising Clinical Pipeline
Repare Therapeutics Inc. Just Reported A Surprise Profit And Analysts Updated Their Estimates
It's been a good week for Repare Therapeutics Inc. (NASDAQ:RPTX) shareholders, because the company has just released its latest first-quarter results, and the shares gained 8.7% to US$3.64. Reve
Repare Therapeutics Shares Rise 17% After 1Q Earnings, Revenue Beats
By Chris Wack Repare Therapeutics shares were up 17% to $3.85 after the company reported first-quarter earnings that beat analysts' expectations. The company reported quarterly earnings of $13 milli
Repare Therapeutics Shares Are Trading Higher Following Better-than-expected Q1 Financial Results.
Repare Therapeutics Shares Are Trading Higher Following Better-than-expected Q1 Financial Results.
Express News | Repare Therapeutics Shares Are Trading Higher Following Better-than-expected Q1 Financial Results
Small Cap Bid Up Following Key Q1 Earnings Beat
Repare Therapeutics RPTX Earnings; Enveric ENVB Patent Licensing
Why RingCentral Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Shares of RingCentral, Inc. (NYSE:RNG) rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results and raised its FY24 guidance.RingCentr
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersRepare Therapeutics (NASDAQ:RPTX) shares rose 34.1% to $4.4 during Wednesday's pre-market session. The company's market cap stands at $186.7 million. The company's, Q1 earnings came out yesterd
Top Premarket Gainers
Innodata (INOD) shares rose 23% Wednesday premarket after the company reported improved Q1 results. Repare Therapeutics (RPTX) shares increased 21% after the company swung to Q1 profit amid higher rev
Analysts Offer Insights on Healthcare Companies: Surgery Partners (SGRY), Repare Therapeutics (RPTX) and Penumbra (PEN)
Repare Therapeutics (RPTX) Gets a Buy From Piper Sandler
Repare Therapeutics Shares Rise Premarket Wednesday After Company Swings to Q1 Net Income Amid Higher Revenue
07:07 AM EDT, 05/08/2024 (MT Newswires) -- Repare Therapeutics Shares Rise Premarket Wednesday After Company Swings to Q1 Net Income Amid Higher Revenue Price: 3.8600, Change: +0.58, Percent Change: +
Analysts' Opinions Are Mixed on These Healthcare Stocks: Repare Therapeutics (RPTX) and Demant (OtherWILLF)
Repare Therapeutics Advances Oncology Trials
Repare Therapeutics Q1 EPS $0.30 Beats $0.02 Estimate, Sales $52.40M Beat $38.40M Estimate
Repare Therapeutics (NASDAQ:RPTX) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $0.02 by 1400 percent. This is a 136.14 percent increase over losses of $(
Repare Therapeutics | 10-Q: Quarterly report
Press Release: Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2024 Financial Results
Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2024 Financial Results
Express News | Repare Therapeutics Q1 Pretax Profit USD 13.791 Million
Express News | Repare Therapeutics Q1 Income From Operations USD 10.816 Million